Does NICE influence the adoption and uptake of generics in the UK? | SpringerLink
How Generic Drugs, Patents, and Price Controls Affect Markets | NBER
Limiting Evergreening for Name-Brand Prescription Drugs | Committee for a Responsible Federal Budget
Generic Price Competition For Specialty Drugs: Too Little, Too Late? | Health Affairs
Generic Competition and Drug Prices | FDA
The consequences of generic entry : price , promotional effort and market share PRELIMINARY | Semantic Scholar
The consequences of generic entry : price , promotional effort and market share PRELIMINARY | Semantic Scholar
The unexpected consequences of generic entry - ScienceDirect
PDF) The Empirical Effect of Generic Competition on Brand-Name Molecules in the U.S. Pharmaceutical Market | Nicholas Debany - Academia.edu
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending - WOUTERS - 2017 - The Milbank Quarterly - Wiley Online Library
The effect of inertia on brand-name versus generic drug choices - ScienceDirect
The unexpected consequences of generic entry - ScienceDirect
The consequences of generic entry: price, promotional effort and market share
Does Entry Remedy Collusion? Evidence From the Generic Prescription Drug Cartel | BFI
Brand vs generic prescription spending share U.S. 2017-2021 | Statista
Competition and price among brand-name drugs in the same class: A systematic review of the evidence | PLOS Medicine
Patent Expiration and Pharmaceutical Prices | NBER
Generic pharmaceutical price decay - Wikipedia
Home | OECD iLibrary
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending - WOUTERS - 2017 - The Milbank Quarterly - Wiley Online Library
Effect of Competition on Generic Drug Prices | SpringerLink
Prescription Drugs: Spending, Use, and Prices | Congressional Budget Office
